Research map: Milsaperidone: First Approval

Back to the article

Papers in this map

  1. A Rating Scale for Mania: Reliability, Validity and Sensitivity · Robert C. Young · 1978 · 8849 citations · Cited by this paper
  2. Effectiveness and Tolerability of Vortioxetine in Major Depressive Disorder: A Real-World Study in Switzerland · 2026 · Related
  3. Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia · Andrew J. Cutler · 2008 · 113 citations · Cited by this paper
  4. Clinical Benefit of Multiple Myeloma Drugs at Regulatory Approval in Brazil, Europe, and the USA: A Retrospective Cohort Study (2003–2024) · 2026 · Related
  5. Efficacy of Iloperidone in the Treatment of Schizophrenia · Steven G. Potkin · 2008 · 89 citations · Cited by this paper
  6. Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles · 2026 · Related
  7. Receptor profile of P88-8991 and P95-12113, metabolites of the novel antipsychotic iloperidone · Natarajan Subramanian · 2002 · 39 citations · Cited by this paper
  8. Determinants and Prognostic Impact of In-Hospital Sodium-Glucose Cotransporter-2 Inhibitor Initiation in Patients with Heart Failure · 2026 · Related
  9. A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study · Peter J. Weiden · 2016 · 29 citations · Cited by this paper
  10. Missed Opportunities in the Therapeutic Patterns of Chronic Obstructive Pulmonary Disease: A Real-World Italian Study on the Impact of Severe Exacerbation on Mortality and Hospital Re-admission · 2026 · Related
  11. Efficacy and Safety of Iloperidone in Bipolar Mania · Rosarelis Torres · 2024 · 11 citations · Cited by this paper
  12. Cost-Consequences Analysis of Biologic Treatments for Moderate-to-Severe Crohn’s Disease Using Real-World Transition Probability and Cost Data in Thailand · 2026 · Related
  13. Amyloid-Related Imaging Abnormalities in Anti-amyloid Therapy: Clinical Implications of Kinetics for Safer Use and Risk Stratification · 2026 · Related
  14. Over-the-Counter Product Use Among Individuals with Vitiligo: A Cross-Sectional International Survey · 2026 · Related
  15. Safety, Tolerability, and Pharmacokinetics of Subcutaneous Extended-Release Injectable Olanzapine in Patients with Schizophrenia and Schizoaffective Disorder · 2026 · Related
  16. A Single-Center, Randomized, Open-Label, Two-Formulation, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of Two Eltrombopag Olamine Tablets (25 mg) in Healthy Chinese Subjects in the Fed State · 2026 · Related

Source: OpenAlex (CC0)